Shigella Test Kit Market to Grow with a CAGR of 6.34% through 2029
Rising Awareness and Healthcare Spending is expected
to drive the Global Shigella Test Kit Market growth in the forecast period, 2025-2029.
According to TechSci Research report, “Shigella Test Kit Market - Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029F”, the Global
Shigella Test Kit Market stood at USD 106.83 Million in 2023 and is anticipated
to grow with a CAGR of 6.34% through 2029. Increased awareness among
healthcare professionals and the public about the importance of early detection
of infectious diseases like Shigella encourages the uptake of diagnostic tools capable
of rapidly and accurately identifying the pathogen. Detecting infections early
is critical as it allows for prompt initiation of treatment, which
significantly impacts patient outcomes and public health. According to the
Canada Medical Association, Canada's total healthcare spending was projected to
reach $344 billion in 2023, equating to approximately $8,740 per Canadian and
representing about 12.1% of the country's GDP. This places Canada among the highest
healthcare spenders within OECD countries. As healthcare spending rises, there
is a corresponding demand for advanced diagnostic technologies that offer
heightened sensitivity, specificity, and rapid turnaround times. Shigella test
kits leveraging molecular techniques such as PCR (Polymerase Chain Reaction) or
nucleic acid amplification fulfill these requirements, driving their adoption
in clinical settings.
Increased healthcare expenditure often accompanies
improvements in healthcare infrastructure, including diagnostic capabilities.
Hospitals and diagnostic laboratories equipped with state-of-the-art facilities
are more likely to invest in advanced diagnostic technologies like Shigella
test kits. These investments aim to enhance diagnostic accuracy and improve
patient care outcomes. The combination of heightened awareness about infectious
diseases and increased healthcare spending creates a favorable environment for
the adoption and expansion of Shigella test kits in healthcare settings. These
factors underscore the importance of early detection, effective disease
management, and the implementation of public health interventions, all of which
contribute to the growth of the Shigella test kit market segment.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on " Global Shigella Test Kit Market”
Global Shigella Test Kit Market is segmented into test
type, technology, end user, regional distribution, and company.
Based on End User, Hospitals emerged as the dominating segment in the
global market for Shigella Test Kit in 2023. Hospitals serve as primary healthcare
providers where patients with suspected Shigella infections seek diagnosis and
treatment. Quick and precise diagnosis is crucial in hospitals to promptly
begin appropriate treatment and prevent the spread of infection within
healthcare environments. Hospitals cater to a diverse patient population,
encompassing individuals with various health conditions and susceptibility to
infections. The demand for Shigella test kits in hospitals reflects the
necessity to diagnose a wide range of patients presenting with gastrointestinal
symptoms, ensuring precise and comprehensive healthcare delivery. Hospitals
frequently encounter outbreaks of infectious diseases such as shigellosis. They
require dependable diagnostic tools like Shigella test kits to swiftly identify
the causative pathogen during outbreaks, implement infection control measures,
and effectively manage patient care. Shigella test kits are seamlessly
integrated into hospitals' clinical workflows, facilitating smooth diagnostic
processes from sample collection to result analysis and reporting. This
integration enhances operational efficiency in patient management and
contributes to improved overall healthcare outcomes. The pivotal role of
hospitals as primary healthcare providers underscores the importance of
accessing advanced diagnostic tools capable of delivering rapid and accurate
results, thereby supporting optimal patient care and public health initiatives.
Based on Region, the North America region emerged as
the dominating region in the global market for Shigella Test Kit in 2023.
North
America possesses advanced healthcare infrastructure with well-equipped
hospitals and diagnostic laboratories capable of adopting and deploying
cutting-edge diagnostic technologies, including Shigella test kits. According
to estimates from the Centers for Disease Control and Prevention (CDC),
approximately 450,000 cases of Shigella infection (shigellosis) occur annually
in the United States, with around 242,000 infections being
antimicrobial-resistant, posing a significant public health concern. Healthcare
providers and the general population in North America exhibit a high level of
awareness regarding infectious diseases, underscoring the demand for effective
diagnostic tools such as Shigella test kits. North America serves as a
prominent center for biomedical research and development, with research
institutions and biotechnology firms continuously innovating in diagnostic
technologies. These advancements contribute significantly to the evolution of
Shigella testing methodologies in the region.
Major companies operating in Global Shigella Test Kit Market are:
- Thermo Fisher
Scientific Inc.
- Meridian
Bioscience, Inc.
- QIAGEN N.V.
- Diasorin S.p.A.
- Bio-Rad
Laboratories Inc.
- BioMérieux SA
- Hygiena LLC
- Molbio
Diagnostics Pvt. Ltd.
- Fujirebio
Diagnostics, Inc.
- CTK Biotech,
Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“Shigella test kits utilize advanced molecular
technologies such as PCR and antigen detection to achieve exceptional accuracy
and efficiency in detecting Shigella bacteria. As awareness of foodborne
illnesses grows worldwide and healthcare systems emphasize quick response
capabilities, there is a rising demand for these sophisticated diagnostic
tools. They not only enable prompt diagnosis and treatment but also
significantly contribute to outbreak prevention and enhance public health
outcomes on a global scale”, said Mr. Karan Chechi, Research Director of
TechSci Research, a research-based management consulting firm.
“Shigella Test Kit Market - Global Industry Size,
Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Lateral
flow assays, Enzyme-linked immunosorbent assay (ELISA), Polymerase chain
reaction (PCR) assay, and Others), By Technology
(Conventional diagnostic tests, Nucleic acid-based tests, and Others), By End
User (Hospitals, Diagnostic laboratories, Research institutes, and Others),
By Region and Competition, 2019-2029F”, has evaluated
the future growth potential of Global Shigella Test Kit Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Shigella Test Kit Market.
Contact
TechSci Research
LLC
420 Lexington Avenue,
Suite 300,
New York, United
States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com